Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

HLA Loss and the Impact on Immunotherapy

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11869495
archived

Loss of the HLA locus impairs presentation of tumor antigens and is frequently found in advanced cancers. This talk presented by Dr Lee Albacker, Foundation Medicine and first recorded at the 2020 IO360° Summit, will describe the landscape of HLA loss and other response biomarkers in a dataset of 90,000 solid tumor samples and highlight the effect of HLA loss on checkpoint inhibitor response. 

To learn more about the upcoming IO360° 2021 Summit please visit www.io360summit.com

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled